Evidence map›Paper›PMID 24806830›Full record

ReviewXenotransplantation

Islet cell xenotransplantation: a serious look toward the clinic.

Kannan P Samy, Benjamin M Martin, Nicole A Turgeon, Allan D Kirk

Abstract readReview
In one paragraph

Review in Xenotransplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Optimization of an OScientific reports · 2022
    Article
  3. Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Extensive germline genome engineering in pigs.Nature biomedical engineering · 2021
    Article
  9. Review
  10. Article
  11. Early barriers to neonatal porcine islet engraftment in a dual transplant model.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2018
    Article
  12. Article
  13. Review
  14. Regenerative medicine and cell-based approaches to restore pancreatic function.Nature reviews. Gastroenterology & hepatology · 2017
    Review
  15. Review
  16. Article
  17. Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2015
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kannan P SamyEmory Transplant Center, Emory University School of Medicine, Atlanta, GA, USA.
Benjamin M Martin
Nicole A Turgeon
Allan D Kirk

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 DiabetesU01AI090956 · NIAID · EMORY UNIVERSITY · PI KIRK, ALLAN D., LUO, XUNRONG · 2010 to 2024
$14.8M
NIAID NIH HHS AI090956NIAID NIH HHS U01 AI090956NIH HHS P51 OD011132
6 · The paper itself

Abstract

Type I diabetes remains a significant clinical problem in need of a reliable, generally applicable solution. Both whole organ pancreas and islet allotransplantation have been shown to grant patients insulin independence, but organ availability has restricted these procedures to an exceptionally small subset of the diabetic population. Porcine islet xenotransplantation has been pursued as a potential means of overcoming the limits of allotransplantation, and several preclinical studies have achieved near-physiologic function and year-long survival in clinically relevant pig-to-primate model systems. These proof-of-concept studies have suggested that xenogeneic islets may be poised for use in clinical trials. In this review, we examine recent progress in islet xenotransplantation, with a critical eye toward the gaps between the current state of the art and the state required for appropriate clinical investigation.

Indexed as

AnimalsDiabetes Mellitus, Type 1Disease Models, AnimalHumansIslets of Langerhans TransplantationPatient SelectionPrimatesSwineTransplantation, Heterologousartificial pancreasclinical trialethicsgenetically engineered animalsimmunosuppressionislet transplantationxenotransplantation

Identifiers

PMID24806830
PMCPMC4047130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.